Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2018

Planlagt Fastgjort Låst Flyttet Genmab
4.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    rex_pacis
    wrote on sidst redigeret af
    #471

    Den som tøver taber 😉

    1 Reply Last reply
    0
    • bongobobB Offline
      bongobobB Offline
      bongobob
      wrote on sidst redigeret af
      #472

      Kun en overskrift: https://www.sciencedirect.com/science/article/pii/S0161589018304255?via%3Dihub

      1 Reply Last reply
      0
      • bongobobB Offline
        bongobobB Offline
        bongobob
        wrote on sidst redigeret af
        #473

        Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency

        1 Reply Last reply
        0
        • bongobobB Offline
          bongobobB Offline
          bongobob
          wrote on sidst redigeret af
          #474

          DuoHexa CD37 i kombi med CD20. Vi får nok masser af denne type nyheder det næste år

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #475

            De skal være velkomne 🙂

            1 Reply Last reply
            0
            • O Offline
              O Offline
              OHW
              wrote on sidst redigeret af
              #476

              arhg...patienterne er nok ikke enige med dig!

              1 Reply Last reply
              0
              • D Offline
                D Offline
                Doc4
                wrote on sidst redigeret af
                #477

                9:05..However, resistance of cancer cells to CDC is a major problem.
                Two FDA-approved CD20 IgG1 mAbs, rituximab and ofatumumab,
                promote only ∼15 and 50% CDC, respectively, of B cells from
                patients with chronic lymphocytic leukemia (CLL)...we report that hexamerization-enhanced mAbs, specific for CD20
                or CD37, induced 95–99% CDC of CLL B cells at concentrations of
                10–16 g/mL in samples from 20 patients. CD37 mAbs without the
                E430G mutation did not mediate CDC...

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  Doc4
                  wrote on sidst redigeret af
                  #478

                  ...High levels of killing of primary cancer cells are
                  unprecedented and provide new opportunities for development of
                  improved antibody therapies exploiting CDC, particularly in CLL.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #479

                    Daratumumab in myeloma update: expanding indications, Niels van de Donk @ ESH - https://www.youtube.com/watch?v=66TVQeKcp38

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #480

                      Update on recent smoldering multiple myeloma trials, Maria-Victoria Mateos @ESH https://www.youtube.com/watch?v=sF_fmbhnc0s

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #481

                        CD38 antibodies under investigation for myeloma: isatuximab, MOR202 & TAK-079 https://www.youtube.com/watch?v=8-oiXhcegjw

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #482

                          Updated CASTOR analysis: daratumumab plus Vd for R/R myeloma https://www.youtube.com/watch?v=2dwYLNTA19s

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #483

                            Så fik vi median. pfs for Castor DVd: aproxx 2 years vs 7 mdr. for Vd og 26 mdr for 1. relaps DVd.

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              mobbyduck1
                              wrote on sidst redigeret af
                              #484

                              ja det er imponerende

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #485

                                og vi ved at Pollux er endnu bedre

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  mobbyduck1
                                  wrote on sidst redigeret af
                                  #486

                                  og 43% CR i 1.Relaps er det også mere end fint

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #487

                                    42 % fik komplet respons efter 1. relaps. Førhen så man slet ikke CR i relapsed setting. Det var kun noget der forekom i 1. linje.

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #488

                                      43% - jeg hørte forkert 🙂

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        mobbyduck1
                                        wrote on sidst redigeret af
                                        #489

                                        sorry 43

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #490

                                          Tusinde tak for link Bulder. http://www.proinvestor.com/index.php?p=debat_1&postid=76324

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger